Home / Top News / Opthea’s Phase 2b Trial in Wet AMD Advances with a Second Positive Independent Safety Committee Recommendation

Opthea’s Phase 2b Trial in Wet AMD Advances with a Second Positive Independent Safety Committee Recommendation

GlobeNewswire

GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
GlobeNewswire